首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Impact of the Renin–Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives
【2h】

Impact of the Renin–Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives

机译:肾素 - 血管紧张素系统对血管痴呆内皮内皮的影响:未解决的问题和未来的观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effects of the renin–angiotensin system (RAS) surpass the renal and cardiovascular systems to encompass other body tissues and organs, including the brain. Angiotensin II (Ang II), the most potent mediator of RAS in the brain, contributes to vascular dementia via different mechanisms, including neuronal homeostasis disruption, vascular remodeling, and endothelial dysfunction caused by increased inflammation and oxidative stress. Other RAS components of emerging significance at the level of the blood–brain barrier include angiotensin-converting enzyme 2 (ACE2), Ang(1–7), and the AT2, Mas, and AT4 receptors. The various angiotensin hormones perform complex actions on brain endothelial cells and pericytes through specific receptors that have either detrimental or beneficial actions. Increasing evidence indicates that the ACE2/Ang(1–7)/Mas axis constitutes a protective arm of RAS on the blood–brain barrier. This review provides an update of studies assessing the different effects of angiotensins on cerebral endothelial cells. The involved signaling pathways are presented and help highlight the potential pharmacological targets for the management of cognitive and behavioral dysfunctions associated with vascular dementia.
机译:肾素 - 血管紧张素系统(RAS)的效果超越肾和心血管系统,包括其他身体组织和器官,包括大脑。血管紧张素II(Ang II)是大脑中Ras中最有效的介质,通过不同的机制促进血管痴呆,包括神经元稳态破坏,血管重塑和由增加的炎症和氧化应激引起的内皮功能障碍。在血脑屏障水平下出现的其他RAS组分包括血管紧张素转换酶2(ACE2),Ang(1-7)和AT2,MAS和AT4受体。各种血管紧张素激素通过具有有害或有益行动的特异性受体对脑内皮细胞和闭梗塞进行复杂的作用。越来越多的证据表明ACE2 / ANG(1-7)/ MAS轴构成血脑屏障对RA的保护臂。该综述提供了评估血管紧张素对脑内皮细胞的不同效果的研究的更新。提出了涉及的信号通路,并有助于突出潜在的药理学靶标,用于管理与血管痴呆相关的认知和行为功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号